tiprankstipranks
Trending News
More News >
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market
Advertisement

Keros Therapeutics (KROS) Technical Analysis

Compare
350 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Keros Therapeutics’s (KROS) Moving Averages Convergence Divergence (MACD) indicator is 0.54, suggesting Keros Therapeutics is a Sell.
Keros Therapeutics’s (KROS) 20-Day exponential moving average is 16.42, while Keros Therapeutics’s (KROS) share price is $16.86, making it a Buy.
Keros Therapeutics’s (KROS) 50-Day exponential moving average is 15.81, while Keros Therapeutics’s (KROS) share price is $16.86, making it a Buy.

Keros Therapeutics (KROS) Pivot Points

Nov 20, 2025, 01:18 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
16.44
16.70
17.13
17.39
17.81
18.07
18.50
Fibonacci
16.70
16.96
17.13
17.39
17.65
17.81
18.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Keros Therapeutics (KROS) Moving Averages

Nov 20, 2025, 01:18 PM
Period
Simple
Exponential
MA5
17.27Sell
17.15Sell
MA10
17.01Sell
16.89Sell
MA20
16.10Buy
16.42Buy
MA50
15.76Buy
15.81Buy
MA100
15.13Buy
15.60Buy
MA200
13.85Buy
16.42Buy
Keros Therapeutics’s (KROS) 10-Day exponential moving average is 16.89, while Keros Therapeutics’s (KROS) share price is $16.86, making it a Sell.
Keros Therapeutics’s (KROS) 100-Day exponential moving average is 15.60, while Keros Therapeutics’s (KROS) share price is $16.86, making it a Buy.
Keros Therapeutics’s (KROS) stock price is $16.86 and Keros Therapeutics’s (KROS) 50-day simple moving average is 15.76, creating a Buy signal.
Keros Therapeutics’s (KROS) stock price is $16.86 and Keros Therapeutics’s (KROS) 100-day simple moving average is 15.13, creating a Buy signal.
Keros Therapeutics’s (KROS) stock price is $16.86 and Keros Therapeutics’s (KROS) 200-day simple moving average is 13.85, creating a Buy signal.

Keros Therapeutics (KROS) Technical Indicators

Nov 20, 2025, 01:18 PM
Name
Value
Implied Action
RSI (14)
58.48
Neutral
STOCH (9,6)
79.88
Neutral
STOCHRSI (14)
86.26
Sell
MACD (12,26)
0.54
Sell
ADX (14)
24.70
Neutral
Williams %R
-28.26
Buy
CCI (14)
54.65
Neutral
ATR (14)
0.72
-
Ultimate Oscillator
62.64
Neutral
ROC
12.18
Buy
Keros Therapeutics’s (KROS) Relative Strength Index (RSI) is 58.48, creating a Neutral signal.
Keros Therapeutics’s (KROS) Trend Strength Indicator (ADX) is 24.70, creating a Neutral signal.
Keros Therapeutics’s (KROS) Commodity Channel Index (CCI) is 54.65, creating a Neutral signal.
Keros Therapeutics’s (KROS) Price Rate of Change (ROC) is 12.18, creating a Buy signal.

FAQ

Is KROS a Buy, Hold, or Sell?
Based on KROS’s technical indicators, KROS is a Buy.
    What is KROS’s RSI (14)?
    KROS’s RSI (14) is 58.48, which suggests KROS is a Neutral.
      What is KROS’s MACD?
      KROS’s MACD is 0.54, which suggests KROS is a Sell.
        What is KROS’s 5-day moving average?
        KROS’s 5-day moving average is 17.27, which suggests KROS is a Sell.
          What is KROS’s 20-day moving average?
          KROS 20-day moving average is 16.10, which suggests KROS is a Buy.
            What is KROS’s 50-day moving average?
            KROS’s 50-day moving average is 15.76, which suggests KROS is a Buy.
              What is KROS’s 200-day moving average?
              KROS’s 200-day moving average is 13.85, which suggests KROS is a Buy.
                What is KROS’s Williams % R (14)?
                KROS’s Williams % R (14) is -28.26, which suggests KROS is a Buy.
                  What is KROS’s CCI (14)?
                  KROS’s CCI (14) is 54.65, which suggests KROS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis